# Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents

Study · id `cardio:ct-nct02464397` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02464397](<https://clinicaltrials.gov/study/NCT02464397>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02464397

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

## Technical summary

Registry record NCT02464397. Randomized; single masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT02464397, source copy `cardio:ctgov-nct02464397-2015-06-08`, retrieved 2026-10-31)
- Start date: 2015-02 (registry gives no type) (ClinicalTrials.gov record NCT02464397, source copy `cardio:ctgov-nct02464397-2015-06-08`, retrieved 2026-10-31)
- Primary completion: 2016-08 (anticipated) (ClinicalTrials.gov record NCT02464397, source copy `cardio:ctgov-nct02464397-2015-06-08`, retrieved 2026-10-31)
- Completion: 2017-08 (anticipated) (ClinicalTrials.gov record NCT02464397, source copy `cardio:ctgov-nct02464397-2015-06-08`, retrieved 2026-10-31)
- Countries: Belgium; Finland (ClinicalTrials.gov record NCT02464397, source copy `cardio:ctgov-nct02464397-2015-06-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02464397-2015-06-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents
- Acronym: OPTIMAX-OCT
- Condition: Acute Coronary Syndrome
- Intervention (Device): Stent
- Lead sponsor: The Hospital District of Satakunta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes (`cardio:pubmed-35752571`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 23c543a1f37cebeef1f2b34d0dbc2cb737c84512c592ff259567256a47af7767
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
